Intressa Vascular announces the first patient enrolment in the EXTENSO clinical study in Germany
Intressa Vascular has initiated the EXtensive mulTilayer stEnt treatmeNt in aortic disSectiOn study to show a reduction in reinterventions and rupture of the aorta in patients with extended TBAD when treated with the Allay® Aortic Stent as adjunctive endovascular treatment to thoracic endovascular repair with stent grafts. The study has now enrolled its first patient in Europe.
Intressa Vascular announces the start of the EXTENSO clinical study
Intressa Vascular is starting a clinical study to evaluate the effectiveness and safety of the Allay® Aortic Stent as adjunctive endovascular treatment of Type B aortic dissection (TBAD) in patients eligible for thoracic endovascular repair with stent grafts, the EXtensive mulTilayer stEnt treatmeNt in aortic disSectiOn study, to reduce reinterventions and rupture of the aorta in patients with extended TBAD.
The Allay® Aortic Stent wins the 2024 Prix Galien for Most Promising Design
The Prix Galien, often likened to the Nobel Prize of medical innovation on the international stage, celebrates the most significant advancements in healthcare.
Denis Gestin is appointed to Intressa Vascular Board of Directors
Intressa Vascular SA, a clinical-stage MedTech company using its proprietary multilayer stent braiding technology to develop an innovative stent for aortic dissection, today announces the appointment of Denis Gestin as independent director.
